Thrombocytopenia complicating preeclampsia: data to support a new model

Area of Science:

• Obstetrics and Gynecology
• Immunology
• Hematology

Background:

• Thrombocytopenia is a common complication of preeclampsia, potentially contributing to placental insufficiency.
• The exact mechanisms linking thrombocytopenia to preeclampsia and placental dysfunction remain unclear.
• Investigating immune-mediated causes of thrombocytopenia in preeclampsia is crucial for understanding disease pathogenesis.

Observation:

• A patient with preeclampsia exhibited in vitro platelet agglutination when her serum was preincubated with her placental cells.
• This platelet agglutination reaction was dependent on calcium and complement.
• Control experiments using sera and placentas from normal pregnancies did not induce platelet agglutination.

Findings:

• The patient's serum and placental cells possessed the capacity to agglutinate her own platelets.
• This platelet-aggregating capacity was absent in postpartum sera collected 60 days after delivery.
• These observations suggest an immune-mediated phenomenon involving platelets and placental factors in preeclampsia.

Implications:

• Platelet involvement in an immune-mediated process may contribute to thrombocytopenia in preeclampsia.
• This phenomenon, potentially amplified within the placenta, could impair placental blood flow.
• Understanding this immune mechanism may offer new diagnostic or therapeutic targets for preeclampsia.